| OCRUZO CELGENE CORPORATION
1769547 25 Feb 2016 | on 15 Aug 2017 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations for the treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; pharmaceutical preparations for the treatment of blood disorders, cancer, and oncological diseases and disorders. | | | OCRUP INFLAMAX RESEARCH LIMITED
1706216 08 Dec 2014 | on 22 Dec 2017 | Class 009 Class 009 Computer & Software Products & Electrical & Scientific Products Computer software, namely, software for patient recruitment and scheduling for clinical trials, software for analysis of patient recruitment and scheduling for clinical trials, computer software for providing an internet website portal offering information in the field of medical research and clinical trials for medical and scientific research. Class 035 Class 035 Advertising, Business & Retail Services Development of computer software for patient recruitment and scheduling for clinical trials; computer software support services; database development and maintenance; clinical services, namely, patient recruitment and scheduling for clinical trials; consulting services, namely, study design for clinical trials for medical and scientific research, patient recruitment for clinical trials for medical and scientific research; development, training and support services in the field of clinical trials for medical and scientific research. Class 041 Education and Entertainment Services
Class 042 Computer & Software Services & Scientific Services | | | OCRUZO CELGENE CORPORATION
1651813 13 Nov 2013 | on 13 Dec 2017 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations for the treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; pharmaceutical preparations for the treatment of blood disorders, cancer, and oncological diseases and disorders. | |